UPS’s healthcare business invests more than €20 million to expand its European temperature-controlled fleet in its four markets

State-of-the-art biological and special pharmaceutical products require precise cold chain logistics, so that critical products for patients reach their destination on time and at the right temperature. As 80% of pharmaceutical products in Europe currently require temperature-controlled transport, cold chain transport is needed more than ever. This is why UPS has decided to commit to another investment in healthcare logistics.

Hungary is one of the main hubs of UPS’s onshore cold chain network, and UPS Healthcare’s headquarters in Budaörs is the company’s key facility in the region for Central and Eastern European imports and exports.

The new vehicles further expand and modernize UPS’s fleet of more than 1,100 refrigerated vehicles, which is currently the largest in the world. With the value of the cold chain market forecast to reach $23.7 billion by 2030, these tools supporting both long-distance and last-mile deliveries will play an essential role in meeting the growing needs of the European healthcare industry.